Brief: Glaxosmithkline Pharma Q3 Consol Profit 2.3 Billion Rupees
14/02/2025 10:05
Feb 14 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* GLAXOSMITHKLINE PHARMA Q3 CONSOL PROFIT 2.3 BILLION RUPEES
* GLAXOSMITHKLINE PHARMA Q3 CONSOL REVENUE FROM OPERATIONS
9.49
BILLION RUPEES
* GLAXOSMITHKLINE PHARMACEUTICALS - RE-APPOINTMENT OF JUBY
CHANDY
AS CHIEF FINANCIAL OFFICER
Source text: ID:nBSE1JhsBH
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees